A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 59 strange trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 54% with bearish.
From the overall spotted trades, 19 are puts, for a total amount of $1,011,517 and 40, calls, for a total amount of $2,109,936.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $310.0 for Moderna over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1538.58 with a total volume of 116,173.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $105.0 to $310.0 over the last 30 days.
Moderna Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 04/14/22 | $230.00 | $207.9K | 1.6K | 30 |
| MRNA | CALL | SWEEP | BULLISH | 03/18/22 | $160.00 | $118.7K | 2.0K | 3.5K |
| MRNA | PUT | SWEEP | BULLISH | 05/20/22 | $220.00 | $109.1K | 304 | 18 |
| MRNA | CALL | SWEEP | BULLISH | 03/18/22 | $175.00 | $100.0K | 651 | 5.5K |
| MRNA | CALL | SWEEP | NEUTRAL | 03/18/22 | $170.00 | $93.9K | 1.2K | 6.6K |
Where Is Moderna Standing Right Now?
- With a volume of 10,940,384, the price of MRNA is up 16.43% at $160.9.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 52 days.
What The Experts Say On Moderna:
- Deutsche Bank has decided to maintain their Hold rating on Moderna, which currently sits at a price target of $155.
- Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently sits at a price target of $205.
- SVB Leerink has decided to maintain their Underperform rating on Moderna, which currently sits at a price target of $81.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
